Abstract:Background & Aims Macrophage inducible C-type lectin (Mincle) is expressed on Kupffer cells and senses ethanol-induced danger signals released from dying hepatocytes and promotes IL-1β production. However, it remains unclear what and how ethanol-induced Mincle ligands activate downstream signaling events to mediate IL-1β release and contribute to alcohol-associated liver disease (ALD). In this study, we investigated the association of circulating β-glucosylceramide (β-GluCer), an endogenous Mincle ligand, with severity of ALD and examined the mechanism by which β-GluCer engages Mincle on Kupffer cells to release IL-1β in the absence of cell death and exacerbates ALD. Approach and Results Concentrations of β-GluCer were increased in serum of patients with severe AH and correlated with disease severity. Challenge of Kupffer cells with LPS and β-GluCer induced formation of a Mincle and Gsdmd -dependent secretory complex containing chaperoned full-length GSDMD (Hsp90-CDC37-NEDD4) with polyubiquitinated pro-IL-1β and components of the Casp8-NLRP3 inflammasome loaded as cargo in small extracellular vesicles (sEV). Gao-binge ethanol exposure to wild-type, but not Mincle -/- and Gsdmd -/- , mice increased release of IL-1β containing sEVs from liver explant cultures. Myeloid-specific deletion of Gsdmd similarly decreased the formation of sEVs by liver explant cultures and protected mice from ethanol-induced liver injury. sEVs collected from ethanol-fed wild-type, but not Gsdmd -/- , mice promoted injury of cultured hepatocytes and, when injected into wild-type mice, aggravated Gao-binge ethanol-induced liver injury. Conclusion β-GluCer functions as a DAMP activating Mincle-dependent GSDMD-mediated formation and release of IL-1β-containing sEVs, which in turn exacerbate hepatocyte cell death and contribute to the pathogenesis of ALD. ### Competing Interest Statement The authors have declared no competing interest. * Mincle : macrophage inducible c-type lectin GSDMD : gasdermin d IL-1β : interleukin-1β β-GluCer : β-glucosylceramide LPS : lipopolysaccharide ALD : alcohol liver disease sEV : small extracellular vesicles AH : alcohol-associated hepatitis Casp : caspase CDC37 : cell deivision cycle 37 HSP90 : heat shock protein 90 NEDD4 : neural precursor cell expressed developmentally down-regulated protein 4 SAP130 : spliceosome-associated protein 130 NLRP3 : NLR family pyrin domain containing 3 MELD : model for end-stage liver disease TDB : trehalose-6,6-dibehenate ATP : adenosine triphosphate DAMP : Damage-associated molecular pattern HC : Healthy control LDH : Lactate Dehydrogenase imKC : immortalized Kupffer cell SAA1 : Serum Amyloid A1 ALT : alanine aminotransferase AST : aspartate aminotransferase TNFa : tumour necrosis factor alpha WT : wild type EtOH : ethanol.

GSDMD Membrane Pore is Critical for IL-1β Release and Antagonizing IL-1β by Hepatocyte-Specific Nanobiologics is a Promising Therapeutics for Murine Alcoholic Steatohepatitis.

Lactobacillus rhamnosus GG supernatant promotes intestinal barrier function, balances Treg and TH17 cells and ameliorates hepatic injury in a mouse model of chronic-binge alcohol feeding.

STING-mediated inflammation contributes to Gao binge ethanol feeding model

Mincle-GSDMD-mediated release of IL-1β containing small extracellular vesicles contributes to ethanol-induced liver injury

Mincle-GSDMD-mediated Release of IL-1β Small Extracellular Vesicles from Hepatic Macrophages in Ethanol-Induced Liver Injury.

Circulating MicroRNAs As Potential Biomarkers for Alcoholic Steatohepatitis.

A Protein Complex of Liver Origin Activates a Pro-inflammatory Program That Drives Hepatic and Intestinal Injury in Alcohol-Associated Liver Disease

Insulin-like Growth Factor Binding Protein 1 Ameliorates Lipid Accumulation and Inflammation in Nonalcoholic Fatty Liver Disease

Inhibition of Glycogen Synthase Kinase 3 Beta Ameliorates Liver Ischemia Reperfusion Injury by Way of an Interleukin-10-mediated Immune Regulatory Mechanism.

XIAP Knockdown in Alcohol-Associated Liver Disease Models Exhibits Divergent in vitro and in vivo Phenotypes Owing to a Potential Zonal Inhibitory Role of SMAC

Post-translational Modifications Drive the Effects of HMGB1 in Alcohol-Associated Liver Disease

Milk‑derived Hexapeptide PGPIPN Prevents and Attenuates Acute Alcoholic Liver Injury in Mice by Reducing Endoplasmic Reticulum Stress

Anti-inflammatory Function of Ginsenoside Rg1 on Alcoholic Hepatitis Through Glucocorticoid Receptor Related Nuclear Factor-Kappa B Pathway

Integrin β1-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH

Glycyrrhizin attenuates hepatic ischemia-reperfusion injury by suppressing HMGB1-dependent GSDMD-mediated kupffer cells pyroptosis

Myeloid Endoplasmic Reticulum Resident Chaperone GP96 Facilitates Inflammation and Steatosis in Alcohol‐Associated Liver Disease

Resolvin D1 attenuated liver injury caused by chronic ethanol and acute LPS challenge in mice

Exosome-Like Nanoparticles From Lactobacillus rhamnosus GG Protect Against Alcohol-Associated Liver Disease Through Intestinal Aryl Hydrocarbon Receptor in Mice

Alternative activation of macrophages by prostacyclin synthase ameliorates alcohol induced liver injury

Gut-restricted apical sodium-dependent bile acid transporter inhibitor attenuates alcohol-induced liver steatosis and injury in mice

IFN-β Overexpressing Adipose-Derived Mesenchymal Stem Cells Mitigate Alcohol-Induced Liver Damage and Gut Permeability